Pramiracetam
CAS No. 68497-62-1
Pramiracetam( CI-879 )
Catalog No. M15617 CAS No. 68497-62-1
A central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 35 | In Stock |
|
| 100MG | 54 | In Stock |
|
| 200MG | 86 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePramiracetam
-
NoteResearch use only, not for human use.
-
Brief DescriptionA central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.
-
DescriptionA central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.Other Indication Approved.
-
In Vitro——
-
In VivoAnimal Model:Male Long Evans hooded rats (250-300 g)Dosage:7.5, 15 mg/kg Administration:i.p.Result:Improved performance in the reference memory component of the task, but did not significantly affect the working memory component.
-
SynonymsCI-879
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number68497-62-1
-
Formula Weight269.3831
-
Molecular FormulaC14H27N3O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C
-
Chemical Name1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Substance P-methyl e...
Substance P, [Met-OMet11] is a selective SP-P agonist. Substance P, [Met-OMet11] also is an active peptide. Substance P, [Met-OMet11] can be used for various biochemical studies.
-
GW6340
GW6340 is a selective LXR agonist with potential anticancer activity that promotes macrophage reverse cholesterol transport (mRCT) and can be used to study atherosclerosis.
-
22393-62-0_peak 2
22393-62-0_peak 2 exhibits some aspects of the antiestrogenic activity and other actions that may be connected to the estrogenic properties.
Cart
sales@molnova.com